Implementation of telehealth support for patients with type 2 diabetes using insulin treatment: An exploratory study

Informatics in Primary Care

Volumn 17, Issue 1, 2009, Pages 47-53

  Turner, Jane ^a   Larsen, Mark ^c   Tarassenko, Lionel ^a,b   Neil, Andrew ^c   Farmer, Andrew ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b Institute of Biomedical Engineering   (China)

^c NONE

Author keywords

Primary care; Telehealth; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

AGED; ARTICLE; BLOOD GLUCOSE MONITORING; FEMALE; HUMAN; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SATISFACTION; QUESTIONNAIRE; SELF CARE; TELEMEDICINE;

AGED; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; PATIENT SATISFACTION; QUESTIONNAIRES; SELF CARE; TELEMEDICINE;

EID: 67651154366     PISSN: 14760320     EISSN: None     Source Type: Journal    
DOI: 10.14236/jhi.v17i1.714     Document Type: Article

References (13)

1. Wagner EH. Chronic disease care. British Medical Journal 2004;328:177-8.
2. Norris SL, Lau J, Smith SJ, Schmid CH and Engelgau MM. Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care 2002;25:1159-71.
3. Holman RR, Paul SK, Bethel MA, Matthews DR and Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. New England Journal of Medicine 2008; 359:1577-89.
4. Colhoun HM, Betteridge DJ, Durrington PN et al. Primary prevention ofcardiovascular disease with atorva- statin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. The Lancet 2004;364:685-96.
5. Gaede P, Vedel P, Larsen N, Jensen GVH, Parving HH and Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. New England Journal ofMedicine 2003;348:383-93. (Pubitemid 36159355)
6. Holman RR, Thorne KI, Farmer AJ et al. Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes. New England Journal of Medicine 2007;357: 1716-30.
7. Korytkowski M. When oral agents fail: practical barriers to starting insulin. International Journal of Obesity 2002; 26:S18-S24.
8. Woolpert HA and Anderson BJ. Management of diabetes: are doctors framing the benefits from the wrong perspective? British Medical Journal 2001;323:994-6.
9. Maheu MM, Whitten P and Allen A. E-health, Telehealth, and Telemedicine: a guide to start-up and success. San Francisco: Jossey-Bass, 2001.
10. Farmer AJ, Gibson OJ, Dudley C et al. A randomized controlled trial of the effect of real-time telemedicine support on glycemic control in young adults with type 1 diabetes (ISRCTN 46889446). Diabetes Care 2005;28: 2697-702.
11. Davies M, Storms F, Shutler S, Bianchi-Biscay M and Gomis R for the AT.LANTUS Study Group. Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine. Diabetes Care 2005; 28:1282-8.
12. Sarkar U, Fisher L and Schillinger D. Is self-efficacy associated with diabetes self-management across race/ethnicityand health literacy? DiabetesCare 2006;29:823-9.
13. Department of Health. Five Years On: delivering the diabetes National Service Framework. London: Department of Health, 2007.